Second Intermezzo "Complete Response" Threatens Transcept's Partnership Payments
This article was originally published in The Pink Sheet Daily
Executive Summary
If approval is not gained by Sept. 23, partner Purdue Pharma will not have to make a $30 million milestone payment.